Edwards Lifesciences Corp. Profit Advances 35% In Q3

(RTTNews) - Edwards Lifesciences Corp. (EW) announced earnings for its third quarter that gained ground from last year.

The company said its bottom line totaled $117.4 million, or $1.07 per share. This was higher than $87.0 million, or $0.80 per share, in last year's third quarter.

Analysts had expected the company to earn $0.98 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 1.3% to $615.5 million. This was up from $607.4 million last year.

Edwards Lifesciences Corp. earnings at a glance:

-Earnings (Q3): $117.4 Mln. vs. $87.0 Mln. last year. -Earnings Growth (Y-o-Y): 34.9% -EPS (Q3): $1.07 vs. $0.80 last year. -EPS Growth (Y-o-Y): 33.8% -Analysts Estimate: $0.98 -Revenue (Q3): $615.5 Mln vs. $607.4 Mln last year. -Revenue Change (Y-o-Y): 1.3%

-Guidance: Next quarter EPS guidance: $1.11 - $1.21 Next quarter revenue guidance: $620 - $660 Mln Full year EPS guidance: $4.43 - $4.53 Full year revenue guidance: $2.3 - $2.5 Bln